BlackRock
NKTR icon

BlackRock’s Nektar Therapeutics NKTR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$10.7M Sell
415,226
-15,292,099
-97% -$395M ﹤0.01% 3323
2025
Q1
$10.7M Sell
15,707,325
-384,256
-2% -$261K ﹤0.01% 3243
2024
Q4
$15M Buy
16,091,581
+122,236
+0.8% +$114K ﹤0.01% 3171
2024
Q3
$20.8M Buy
15,969,345
+813,672
+5% +$1.06M ﹤0.01% 2976
2024
Q2
$18.8M Buy
15,155,673
+9,277,380
+158% +$11.5M ﹤0.01% 2981
2024
Q1
$5.49M Sell
5,878,293
-225,924
-4% -$211K ﹤0.01% 3576
2023
Q4
$3.45M Sell
6,104,217
-1,580,412
-21% -$893K ﹤0.01% 3769
2023
Q3
$4.58M Sell
7,684,629
-919,693
-11% -$548K ﹤0.01% 3632
2023
Q2
$4.95M Sell
8,604,322
-26,954,636
-76% -$15.5M ﹤0.01% 3657
2023
Q1
$25M Sell
35,558,958
-371,757
-1% -$261K ﹤0.01% 2803
2022
Q4
$81.2M Buy
35,930,715
+880,196
+3% +$1.99M ﹤0.01% 2128
2022
Q3
$112M Buy
35,050,519
+3,477,606
+11% +$11.1M ﹤0.01% 1878
2022
Q2
$120M Buy
31,572,913
+5,458,398
+21% +$20.7M ﹤0.01% 1885
2022
Q1
$141M Sell
26,114,515
-557,288
-2% -$3M ﹤0.01% 1891
2021
Q4
$360M Buy
26,671,803
+7,827,559
+42% +$106M 0.01% 1276
2021
Q3
$338M Buy
18,844,244
+247,972
+1% +$4.45M 0.01% 1298
2021
Q2
$319M Sell
18,596,272
-430,864
-2% -$7.39M 0.01% 1418
2021
Q1
$381M Buy
19,027,136
+649,056
+4% +$13M 0.01% 1245
2020
Q4
$312M Buy
18,378,080
+401,898
+2% +$6.83M 0.01% 1261
2020
Q3
$298M Sell
17,976,182
-706,945
-4% -$11.7M 0.01% 1076
2020
Q2
$433M Buy
18,683,127
+613,992
+3% +$14.2M 0.02% 806
2020
Q1
$323M Sell
18,069,135
-348,400
-2% -$6.22M 0.02% 850
2019
Q4
$398M Buy
18,417,535
+4,859,255
+36% +$105M 0.02% 969
2019
Q3
$247M Buy
13,558,280
+293,293
+2% +$5.34M 0.01% 1246
2019
Q2
$472M Buy
13,264,987
+749,644
+6% +$26.7M 0.02% 778
2019
Q1
$421M Sell
12,515,343
-463,835
-4% -$15.6M 0.02% 847
2018
Q4
$427M Sell
12,979,178
-142,578
-1% -$4.69M 0.02% 740
2018
Q3
$800M Buy
13,121,756
+463,152
+4% +$28.2M 0.03% 503
2018
Q2
$618M Sell
12,658,604
-1,812,404
-13% -$88.5M 0.03% 601
2018
Q1
$1.54B Sell
14,471,008
-6,960,380
-32% -$740M 0.07% 268
2017
Q4
$1.28B Buy
21,431,388
+431,269
+2% +$25.8M 0.06% 315
2017
Q3
$504M Buy
21,000,119
+778,640
+4% +$18.7M 0.03% 659
2017
Q2
$395M Buy
20,221,479
+185,933
+0.9% +$3.63M 0.02% 779
2017
Q1
$470M Buy
20,035,546
+20,024,448
+180,433% +$470M 0.03% 679
2016
Q4
$136K Sell
11,098
-1,787
-14% -$21.9K ﹤0.01% 2318
2016
Q3
$221K Buy
12,885
+1,204
+10% +$20.7K ﹤0.01% 2054
2016
Q2
$166K Buy
11,681
+2,668
+30% +$37.9K ﹤0.01% 2175
2016
Q1
$124K Buy
9,013
+3,858
+75% +$53.1K ﹤0.01% 1856
2015
Q4
$87K Buy
5,155
+2,163
+72% +$36.5K ﹤0.01% 1787
2015
Q3
$33K Sell
2,992
-453
-13% -$5K ﹤0.01% 2083
2015
Q2
$43K Sell
3,445
-232
-6% -$2.9K ﹤0.01% 1992
2015
Q1
$40K Hold
3,677
﹤0.01% 2009
2014
Q4
$57K Hold
3,677
﹤0.01% 1862
2014
Q3
$45K Hold
3,677
﹤0.01% 1911
2014
Q2
$47K Sell
3,677
-109
-3% -$1.39K ﹤0.01% 1907
2014
Q1
$46K Buy
3,786
+173
+5% +$2.1K ﹤0.01% 1929
2013
Q4
$41K Sell
3,613
-129
-3% -$1.46K ﹤0.01% 1970
2013
Q3
$39K Buy
3,742
+143
+4% +$1.49K ﹤0.01% 1924
2013
Q2
$41K Buy
+3,599
New +$41K ﹤0.01% 1926